Status:
COMPLETED
Naltrexone Implants vs. MMT Among Inmates in the Norwegian Correctional Services
Lead Sponsor:
University of Oslo
Collaborating Sponsors:
The Research Council of Norway
Conditions:
Opiate Addiction
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
The purpose of this clinical trial is to study the efficacy and safety of naltrexone implants as a relapse prevention for opiate addicted inmates about to be released from prison. The experimental gro...
Detailed Description
The probability of quick relapse to criminal activity and substance abuse after prison release is high among incarcerated opiate addicts. We attempt to prevent relapse to opiate abuse by two differen...
Eligibility Criteria
Inclusion
- opiate addiction
- living in greater Oslo area
Exclusion
- psychosis / major depression, currently not treated
- pregnancy
- liver enzymes: ASAT or ALAT \> threefold above upper boundary
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT00204243
Start Date
May 1 2005
End Date
December 1 2008
Last Update
May 19 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unit for Addiction Medicine
Oslo, Norway, 0407